文献速递淋巴瘤

RUNX3在自然杀伤/T细胞淋巴瘤中具有致癌性并受MYC转录调控

RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.
PubMed 文献 · Leukemia · 2017-01-25

在鼻型结外自然杀伤(NK)/T细胞淋巴瘤(NKTL)患者样本和细胞系中观察到RUNX3 mRNA和蛋白表达上调;沉默RUNX3可增加NKTL细胞凋亡并减少增殖;MYC与RUNX3增强子结合并正向调控其转录,小分子MYC抑制剂JQ1可下调MYC和RUNX3并诱导NKTL细胞凋亡。

要点

  • NKTL患者样本和细胞系中RUNX3 mRNA和蛋白表达较正常NK细胞上调。
  • 沉默RUNX3使NKTL细胞凋亡增加、增殖减少,提示RUNX3具致癌功能。
  • MYC与RUNX3增强子结合并正向调控其转录,JQ1可下调MYC和RUNX3并诱导凋亡。

核心结论

  • 本研究在NKTL中鉴定出RUNX3过表达并具有功能性致癌特性,MYC可能是RUNX3上调的重要上游驱动因素,鉴于MYC在NKTL中上调,进一步研究MYC抑制作为治疗策略是必要的。

研究设计与样本

  • 研究比较NKTL患者样本和NKTL细胞系与正常NK细胞中RUNX3 mRNA和蛋白表达,并在NKTL细胞中进行RUNX3沉默、染色质免疫沉淀-定量PCR、共转染MYC表达载体与RUNX3增强子报告质粒及JQ1处理等实验。

主要发现

  • 与正常NK细胞相比,NKTL患者样本和NKTL细胞系中RUNX3 mRNA和蛋白表达上调。
  • RUNX3沉默的NKTL细胞显示凋亡增加和细胞增殖减少。
  • 在RUNX3增强子区域鉴定出MYC的潜在结合位点,染色质免疫沉淀-定量PCR显示MYC与RUNX3之间存在结合活性。
  • MYC表达载体与RUNX3增强子报告质粒共转染导致RUNX3增强子激活,表明MYC在NKTL细胞系中正向调控RUNX3转录。
  • 小分子MYC抑制剂JQ1处理导致MYC和RUNX3显著下调,并导致NKTL细胞凋亡;JQ1耗竭MYC所致的生长抑制可被外源性MYC表达挽救。

局限性

  • 原文结论指出,进一步研究MYC抑制作为治疗策略是必要的。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RUNX3, runt-domain transcription factor, is a master regulator of gene expression in major developmental pathways. It acts as a tumor suppressor in many cancers but is oncogenic in certain tumors. We observed upregulation of RUNX3 mRNA and protein expression in nasal-type extranodal natural killer (NK)/T-cell lymphoma (NKTL) patient samples and NKTL cell lines compared to normal NK cells. RUNX3 silenced NKTL cells showed increased apoptosis and reduced cell proliferation. Potential binding sites for MYC were identified in the RUNX3 enhancer region. Chromatin immunoprecipitation-quantitative PCR revealed binding activity between MYC and RUNX3. Co-transfection of the MYC expression vector with RUNX3 enhancer reporter plasmid resulted in activation of RUNX3 enhancer indicating that MYC positively regulates RUNX3 transcription in NKTL cell lines. Treatment with a small-molecule MYC inhibitor (JQ1) caused significant downregulation of MYC and RUNX3, leading to apoptosis in NKTL cells. The growth inhibition resulting from depletion of MYC by JQ1 was rescued by ectopic MYC expression. In summary, our study identified RUNX3 overexpression in NKTL with functional oncogenic properties. We further delineate that MYC may be an important upstream driver of RUNX3 upregulation and since MYC is upregulated in NKTL, further study on the employment of MYC inhibition as a therapeutic strategy is warranted.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Selvarajan V, Osato M, Nah GSS, et al. RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC. Leukemia. 2017. PMID: 28119527. doi:10.1038/leu.2017.40

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。